AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 163 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $13,898,000 | +221.3% | 575,000 | +155.6% | 2.65% | +140.2% |
| Q3 2019 | $4,325,000 | +18.7% | 225,000 | +200.0% | 1.10% | +42.4% |
| Q3 2017 | $3,645,000 | -63.5% | 75,000 | -65.9% | 0.77% | -58.4% |
| Q1 2017 | $9,977,000 | +50.6% | 220,000 | +25.7% | 1.86% | +16.6% |
| Q4 2016 | $6,624,000 | -58.7% | 175,000 | -58.8% | 1.59% | -38.7% |
| Q3 2016 | $16,040,000 | – | 425,000 | – | 2.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
| DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
| Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
| PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
| DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |